PRESS RELEASE published on 11/12/2023 at 16:00, 2 years 9 months ago ThinkDiffusionXL: A Groundbreaking Free A.I. Art Model for the Open-Source Community
PRESS RELEASE published on 11/12/2023 at 15:00, 2 years 9 months ago Think Diffusion Integrates ComfyUI: Revolutionizing Easy Access to Stable Diffusion With the Breakthrough Interface
PRESS RELEASE published on 11/11/2023 at 15:00, 2 years 10 months ago Think Diffusion Revolutionizes AI Art With Comprehensive Stable Diffusion Platforms
Published on 09/12/2026 at 02:35, 8 hours 45 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 12 hours 20 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 13 hours 15 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 13 hours 55 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 18 hours 20 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 3 hours 49 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 13 hours 5 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 13 hours 9 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 15 hours 35 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 17 hours 4 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 4 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 4 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 15 hours ago Availability of the 2026 Interim Financial Report
